We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Revvies Energy (RE) is a nutrition company that argues that its innovative energy strips are a game-changer. The company stresses that 80% of the world's population consumes caffeine every day, which takes at least 45 minutes to an hour to reach its peak. RE states that its energy strips dissolve on the tongue in seconds, providing a faster and efficient performance boost that is less than two calories, vegan and gluten-free. RE has sold over 400,000 packs to date and stocked in more than 400 locations across five countries in entities like Chemist Warehouse Australia, Decathlon Australia, and Amazon marketplaces in the UK, US and Australia. RE was awarded 2021's 'Product Of The Year' in 'Sports Nutrition' by NutraIngredients, Europe's leading nutrition industry title. The company works with athletes across various sports, including RE's Ambassadors Charlotte Purdue (British Marathon Champion 2019 ), top US marathoner, Sara Hall, and dual Australian Olympian, Eloise Wellings. RE states it will use the investment to scale its marketing formula both in the UK and international markets.
days to go: Expired investment: £189,363
First Natural Brands is the owner of Tisserand Aromatherapy, one of the leading self-governing players in UK’s essential oil industry. It offers a variety of affordable organic and quality accredited products which consumers can relish as part of their daily lifestyle. Tisserand Aromatherapy is experiencing a growing interest among media, retail and consumers. Since 2007, the company’s sales have increased from £1.7mn to £6mn, owing to Robin Russell (CEO & Chairman) for bringing Tisserand into the mainstream market with a value for money proposition. Further investment will allow the company to expand its production capacity.
days to go: Expired investment: £325,660
Occuity seeks to develop revolutionary non-invasive screening and monitoring devices for chronic diseases like diabetes and Alzheimer's. It argues that its device safely shines a low power beam of light into the eye and then collects and analyses the return signal to accurately measure structures within the eye and detect changes associated with the onset of the aforementioned diseases. Occuity is targeting three distinct markets, namely Ophthalmology, Disease Screening and Disease Monitoring, which is worth an estimated $35 billion per year. It claims that its 'Occuity Indigo' product enables earlier detection of diabetes and provides a non-contacting, pain-free glucose monitor. Occuity was awarded over £1.5 million as part of the Innovate UK grant for the development of technology within Occuity Indigo. It has also signed a partnership with one of the UK's leading ophthalmic distributors, Birmingham Optical, to distribute its PM1 pachymeter device. It states it will use 42% of the investment towards Research and Development (R&D), 23% towards sales and marketing, 20% towards management and finance, 9% towards managing CAPEX and NRE, and 6% towards paying fees.
days to go: Expired investment: £2,854,857
Future You Cambridge is a company that sells clinically proven health supplements directly to consumers. Since its launch in 2016, it has sold products to over 100,000 customers. The company's Lactolycopene product received a patent in December 2017 and its Fertility+ product was also covered by the European Journal of Nutrition in a clinical paper and was shown to have resulted in a 40% increase in male fertility. The company's offerings now stand at 24 products, including the popular CBD product and its first product for pets, Curcupet-K9. Additionally, the company won the 2018 Cambridge Service Excellence and Independent High Growth Business of the Year Awards and has 5-star ratings on Trustpilot. They will use the investment to scale up direct advertising campaigns, expand its product range by more than 10 new products, and invest in their website to make it more intuitive.

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £655,011
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £891,790
OXTO Energy is an energy storage technology provider that intends to transform the way energy is stored. It claims to have developed an innovative energy storage flywheel technology made using 100% recyclable steel, having a low cost of operation, and being easy to manufacture. It argues that it has secured approximately £1.7 million worth of revenues through contracts for 2021 in UK, Kenya, and France, to name a few. It also aspires to become a minority partner of large infrastructure projects by offering its units at a discounted rate, guaranteeing a consistent revenue stream while increasing profitability throughout the project. It wants to dominate the estimated £70 billion energy storage market. The company states it will use 25% of the investment to grow its team, 60% for project delivery, and 15% towards growth and commercialisation of its business.
days to go: Expired investment: £635,493
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
An apron and oven gloves combo that is all about function, as well as form. A multipurpose product fit for baking, barbecuing and cooking which won Gift of The Year 2017. After a highly successful sales event in conjunction with Costco, the business's products are now nationally available. Lobster Homeware is an ethical company and is partnered with the UK's oldest military charity, SSAFA.
days to go: Expired investment: £32,840
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go: Expired investment: £182,281
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go: Expired investment: £136,827
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph